Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Cardio-embolic Stroke Using Anti-vitamin K and Direct Oral Anticoagulants. A Model of Action in Burgundy.

NCT03292575 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT03292575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Cardio-embolic Stroke Using Anti-vitamin K and Direct Oral Anticoagulants. A Model of Action in Burgundy.
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
December 31, 2018
Enrollment
441 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke